Bourgoin S, Plante E, Gaudry M, Naccache P H, Borgeat P, Poubelle P E
Unité de Recherche Inflammation et Immunologie-Rhumatologie, Centre de Recherche du CHUL, Centre Hospitalier de l'Université Laval, Sainte-Foy, Québec, Canada.
J Exp Med. 1990 Sep 1;172(3):767-77. doi: 10.1084/jem.172.3.767.
The generation of diradylglycerol (DRG) and phosphatidic acid (PdtOH) was investigated in neutrophils primed with granulocyte-macrophage colony-stimulating factor (GM-CSF). Mass accumulation of DRG and PdtOH was measured using reversed-phase high performance liquid chromatography and thin layer chromatography, respectively. GM-CSF had no direct effect on the levels of PdtOH and DRG, but it increased PdtOH generation and the late phase of DRG accumulation in human neutrophils stimulated with FMLP. The elevation of the mass of PdtOH peaked approximately 100 s and clearly preceded that of DRG, which peaked at 150 s. The diacylglycerol kinase inhibitor R59022 enhanced the sustained increase in DRG but did not produce a parallel inhibition in PdtOH production. GM-CSF was without effect on the level of inositol 1,4,5-triphosphate [Ins(1,4,5)P3] and did not affect the liberation of Ins(1,4,5)P3 induced by FMLP. These findings exclude the involvement of the PtdIns(4,5)P2-specific phospholipase C/diacylglycerol pathway in the sustained phase of DRG accumulation. The early (30-s) appearance of PdtOH clearly suggests that GM-CSF enhanced FMLP receptor-linked phospholipase D (PLD) generation of PdtOH. PLD was assessed more directly by formation of labeled phosphatidylethanol (PEt) through PLD capacity of catalyzing a trans-phosphatidylation in presence of ethanol. The formation of PEt associated with a concomitant decrease in PdtOH directly demonstrated that the mechanism by which GM-CSF enhances PdtOH production is activation of a PLD active on phosphatidylcholine. This study provides evidence that the mechanism of action of GM-CSF involves upregulation of PLD activity leading to enhanced generation of PdtOH and DRG in FMLP-stimulated neutrophils. These findings may provide the basis for several of the priming effects of GM-CSF.
研究了用粒细胞巨噬细胞集落刺激因子(GM-CSF)预处理的中性粒细胞中甘油二酯(DRG)和磷脂酸(PdtOH)的生成情况。分别使用反相高效液相色谱法和薄层色谱法测定DRG和PdtOH的质量积累。GM-CSF对PdtOH和DRG的水平没有直接影响,但它增加了用FMLP刺激的人中性粒细胞中PdtOH的生成以及DRG积累的后期阶段。PdtOH质量的升高在大约100秒时达到峰值,明显先于DRG的峰值,DRG在150秒时达到峰值。二酰基甘油激酶抑制剂R59022增强了DRG的持续增加,但对PdtOH的产生没有产生平行抑制作用。GM-CSF对肌醇1,4,5-三磷酸[Ins(1,4,5)P3]的水平没有影响,也不影响FMLP诱导的Ins(1,4,5)P3的释放。这些发现排除了磷脂酰肌醇-4,5-二磷酸特异性磷脂酶C/二酰基甘油途径参与DRG积累的持续阶段。PdtOH的早期(30秒)出现清楚地表明GM-CSF增强了FMLP受体连接的磷脂酶D(PLD)生成PdtOH的能力。通过在乙醇存在下PLD催化转磷脂酰化形成标记的磷脂酰乙醇(PEt)来更直接地评估PLD。PEt的形成伴随着PdtOH的相应减少,直接证明了GM-CSF增强PdtOH产生的机制是激活了对磷脂酰胆碱有活性的PLD。这项研究提供了证据,表明GM-CSF的作用机制涉及上调PLD活性,导致在FMLP刺激的中性粒细胞中PdtOH和DRG的生成增加。这些发现可能为GM-CSF的几种预处理作用提供基础。